APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025199 pages

Choose your research edition.

Industry ResearchPorcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include China Animal Husbandry Co., Ltd., Yongshun Biological, Tiankang, Zoetis, Ruipu Biological, Qilu Animal Health, Pulike Biological, Jinyu and Sinopharm Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Company

China Animal Husbandry Co., Ltd.

Yongshun Biological

Tiankang

Zoetis

Ruipu Biological

Qilu Animal Health

Pulike Biological

Jinyu

Sinopharm Animal Health

Dahuanong

Boehringer Ingelheim

Phibro Animal Health

MSD Animal Health

Komipharm

Ceva

CAVAC

Bioveta

Agrovet

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type

Live vaccines

Inactivated vaccines

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application

Government bidding

Market sales

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends Table 2. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers Table 3. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges Table 4. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints Table 5. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers Table 9. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers, Product Type & Application Table 13. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Live vaccines Table 17. Major Manufacturers of Inactivated vaccines Table 18. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Government bidding Table 29. Major Manufacturers of Market sales Table 30. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2027-2032) Table 62. China Animal Husbandry Co., Ltd. Company Information Table 63. China Animal Husbandry Co., Ltd. Business Overview Table 64. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 66. China Animal Husbandry Co., Ltd. Recent Development Table 67. Yongshun Biological Company Information Table 68. Yongshun Biological Business Overview Table 69. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 71. Yongshun Biological Recent Development Table 72. Tiankang Company Information Table 73. Tiankang Business Overview Table 74. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 76. Tiankang Recent Development Table 77. Zoetis Company Information Table 78. Zoetis Business Overview Table 79. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 81. Zoetis Recent Development Table 82. Ruipu Biological Company Information Table 83. Ruipu Biological Business Overview Table 84. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 86. Ruipu Biological Recent Development Table 87. Qilu Animal Health Company Information Table 88. Qilu Animal Health Business Overview Table 89. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 91. Qilu Animal Health Recent Development Table 92. Pulike Biological Company Information Table 93. Pulike Biological Business Overview Table 94. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 96. Pulike Biological Recent Development Table 97. Jinyu Company Information Table 98. Jinyu Business Overview Table 99. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 101. Jinyu Recent Development Table 102. Sinopharm Animal Health Company Information Table 103. Sinopharm Animal Health Business Overview Table 104. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 106. Sinopharm Animal Health Recent Development Table 107. Dahuanong Company Information Table 108. Dahuanong Business Overview Table 109. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 111. Dahuanong Recent Development Table 112. Boehringer Ingelheim Company Information Table 113. Boehringer Ingelheim Business Overview Table 114. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 116. Boehringer Ingelheim Recent Development Table 117. Phibro Animal Health Company Information Table 118. Phibro Animal Health Business Overview Table 119. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 121. Phibro Animal Health Recent Development Table 122. MSD Animal Health Company Information Table 123. MSD Animal Health Business Overview Table 124. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 126. MSD Animal Health Recent Development Table 127. Komipharm Company Information Table 128. Komipharm Business Overview Table 129. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 131. Komipharm Recent Development Table 132. Ceva Company Information Table 133. Ceva Business Overview Table 134. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 136. Ceva Recent Development Table 137. CAVAC Company Information Table 138. CAVAC Business Overview Table 139. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 141. CAVAC Recent Development Table 142. Bioveta Company Information Table 143. Bioveta Business Overview Table 144. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 146. Bioveta Recent Development Table 147. Agrovet Company Information Table 148. Agrovet Business Overview Table 149. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 151. Agrovet Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List Table 155. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Image Figure 2. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032) & (k units) Figure 5. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Live vaccines Image Figure 9. Inactivated vaccines Image Figure 10. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Government bidding Image Figure 17. Market sales Image Figure 18. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Live vaccines
  • Inactivated vaccines
Applications
  • Government bidding
  • Market sales
Companies covered
  • China Animal Husbandry Co., Ltd.
  • Yongshun Biological
  • Tiankang
  • Zoetis
  • Ruipu Biological
  • Qilu Animal Health
  • Pulike Biological
  • Jinyu
  • Sinopharm Animal Health
  • Dahuanong
  • Boehringer Ingelheim
  • Phibro Animal Health
  • MSD Animal Health
  • Komipharm
  • Ceva
  • CAVAC
  • Bioveta
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics
  1. 2.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
  2. 2.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers
  3. 2.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges
  4. 2.4 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints
3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Manufacturers
  1. 3.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Tier 1, Tier 2, and Tier 3
4 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Type
  1. 4.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Type Introduction
  2. 4.1.1 Live vaccines
  3. 4.1.2 Inactivated vaccines
  4. 4.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
  5. 4.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type
  9. 4.3.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032)
5 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Application
  1. 5.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Application Introduction
  2. 5.1.1 Government bidding
  3. 5.1.2 Market sales
  4. 5.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
  5. 5.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application
  9. 5.3.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032)
6 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region
  1. 6.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region
  1. 7.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region
  2. 7.1.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 China Animal Husbandry Co., Ltd.
  2. 8.1.1 China Animal Husbandry Co., Ltd. Company Information
  3. 8.1.2 China Animal Husbandry Co., Ltd. Business Overview
  4. 8.1.3 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  6. 8.1.5 China Animal Husbandry Co., Ltd. Recent Developments
  7. 8.2 Yongshun Biological
  8. 8.2.1 Yongshun Biological Company Information
  9. 8.2.2 Yongshun Biological Business Overview
  10. 8.2.3 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  12. 8.2.5 Yongshun Biological Recent Developments
  13. 8.3 Tiankang
  14. 8.3.1 Tiankang Company Information
  15. 8.3.2 Tiankang Business Overview
  16. 8.3.3 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  18. 8.3.5 Tiankang Recent Developments
  19. 8.4 Zoetis
  20. 8.4.1 Zoetis Company Information
  21. 8.4.2 Zoetis Business Overview
  22. 8.4.3 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  24. 8.4.5 Zoetis Recent Developments
  25. 8.5 Ruipu Biological
  26. 8.5.1 Ruipu Biological Company Information
  27. 8.5.2 Ruipu Biological Business Overview
  28. 8.5.3 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  30. 8.5.5 Ruipu Biological Recent Developments
  31. 8.6 Qilu Animal Health
  32. 8.6.1 Qilu Animal Health Company Information
  33. 8.6.2 Qilu Animal Health Business Overview
  34. 8.6.3 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  36. 8.6.5 Qilu Animal Health Recent Developments
  37. 8.7 Pulike Biological
  38. 8.7.1 Pulike Biological Company Information
  39. 8.7.2 Pulike Biological Business Overview
  40. 8.7.3 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  42. 8.7.5 Pulike Biological Recent Developments
  43. 8.8 Jinyu
  44. 8.8.1 Jinyu Company Information
  45. 8.8.2 Jinyu Business Overview
  46. 8.8.3 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  48. 8.8.5 Jinyu Recent Developments
  49. 8.9 Sinopharm Animal Health
  50. 8.9.1 Sinopharm Animal Health Company Information
  51. 8.9.2 Sinopharm Animal Health Business Overview
  52. 8.9.3 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  54. 8.9.5 Sinopharm Animal Health Recent Developments
  55. 8.10 Dahuanong
  56. 8.10.1 Dahuanong Company Information
  57. 8.10.2 Dahuanong Business Overview
  58. 8.10.3 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  60. 8.10.5 Dahuanong Recent Developments
  61. 8.11 Boehringer Ingelheim
  62. 8.11.1 Boehringer Ingelheim Company Information
  63. 8.11.2 Boehringer Ingelheim Business Overview
  64. 8.11.3 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  66. 8.11.5 Boehringer Ingelheim Recent Developments
  67. 8.12 Phibro Animal Health
  68. 8.12.1 Phibro Animal Health Company Information
  69. 8.12.2 Phibro Animal Health Business Overview
  70. 8.12.3 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  72. 8.12.5 Phibro Animal Health Recent Developments
  73. 8.13 MSD Animal Health
  74. 8.13.1 MSD Animal Health Company Information
  75. 8.13.2 MSD Animal Health Business Overview
  76. 8.13.3 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  78. 8.13.5 MSD Animal Health Recent Developments
  79. 8.14 Komipharm
  80. 8.14.1 Komipharm Company Information
  81. 8.14.2 Komipharm Business Overview
  82. 8.14.3 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  84. 8.14.5 Komipharm Recent Developments
  85. 8.15 Ceva
  86. 8.15.1 Ceva Company Information
  87. 8.15.2 Ceva Business Overview
  88. 8.15.3 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  90. 8.15.5 Ceva Recent Developments
  91. 8.16 CAVAC
  92. 8.16.1 CAVAC Company Information
  93. 8.16.2 CAVAC Business Overview
  94. 8.16.3 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  96. 8.16.5 CAVAC Recent Developments
  97. 8.17 Bioveta
  98. 8.17.1 Bioveta Company Information
  99. 8.17.2 Bioveta Business Overview
  100. 8.17.3 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  102. 8.17.5 Bioveta Recent Developments
  103. 8.18 Agrovet
  104. 8.18.1 Agrovet Company Information
  105. 8.18.2 Agrovet Business Overview
  106. 8.18.3 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  108. 8.18.5 Agrovet Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Analysis
  2. 9.1.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
  6. 9.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
  9. 9.2.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst